GCS centers to help COVID-19 researchers gain expedited access to computing resources

NewsGuard 100/100 Score

Effective immediately, the Gauss Centre for Supercomputing (GCS), the alliance of Germany's three national supercomputing centers, will be helping researchers working on COVID-19 research gain expedited access to computing resources. This includes access to the petascale high-performance computing infrastructures at the High-Performance Computing Center Stuttgart (HLRS), Jülich Supercomputing Centre (JSC), and Leibniz Supercomputing Centre (LRZ).

Recognizing the urgency of the need for new strategies to contain the global pandemic, the three GCS centers have committed to fast-tracking applications for COVID-19 related computing time, minimizing all hurdles during the application process. This applies to research at the molecular level to understand the virus and develop vaccines and therapeutics, epidemiological research to understand and forecast disease spread, and other related approaches aimed at understanding and halting the pandemic.

Computational approaches can provide unique and critical insights into the biology and transmission of disease. GCS is committed to doing everything it can to support the fight against the coronavirus, providing computing time as well as technical support to investigators working to contain its effects."

Dr. Dieter Kranzlmüller, leader of the Leibniz Supercomputing Centre and GCS Chair

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
COVID-19 booster enhances virus neutralizing antibodies in breast milk, new study reveals